Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
about
The association between drospirenone and hyperkalemia: a comparative-safety studyEstrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.Vascular effects of estrogenic menopausal hormone therapy.How full is our antihypertensives pipeline?Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women.Effect of combined drospirenone with estradiol for hypertensive postmenopausal women: a systemic review and meta-analysis.Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiolManaging cardiovascular risk in menopausal women.Drospirenone and estradiol: a new option for the postmenopausal woman.Menopause and cardiovascular disease: the evidence.Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women.Drospirenone: a novel progestin.Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen.Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome.Comparative effects of conventional vs. novel hormone replacement therapy on blood pressure in postmenopausal women.A review of the cardiovascular and breast actions of drospirenone in preclinical studies.Hypertension in women: the role of progesterone and aldosterone.Combination of drospirenone and estradiol: a new hormone therapy in postmenopausal women.One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective study.Effects of estradiol-drospirenone hormone treatment on carotid artery intima-media thickness and vertigo/dizziness in postmenopausal women.Coadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover study.Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function.
P2860
Q34114759-C3864D98-6E62-47EB-89B0-52862A99DA17Q34375771-2C0797F6-86E5-47D7-9B3F-A30693675A17Q35583311-C3742201-1DD8-4366-9DBE-D35A2C3AA580Q35770676-29214E64-8BEA-4613-9997-9694EEA80D3FQ36016412-D7C43D3C-07C5-4C62-A6F3-B5550B51D125Q36016866-7C555CF8-4339-444C-89A8-C65B1C70768DQ36410060-146619A0-2542-42DD-90F8-E0F35E8FE805Q36561361-80850E38-CDDE-46D6-A0D1-7BA24955C3B7Q36761429-0343C1B2-8AB1-405E-B33A-9F369B08199EQ36761433-E39B8830-7E1E-4479-9EE9-A53B74BA2A8EQ36761442-EE638C08-8CD8-42FA-9C32-C78C195E2654Q36808051-333DBA72-FB9D-47F9-911B-4F7C77685470Q37020195-D50CEEA5-931C-48EA-B539-40E6DE83568DQ37030687-A154B270-2485-48CB-B851-9BB10D69C327Q37471083-334D3F3D-B806-48C0-8656-B0F927096EC3Q37610396-612F62FC-8FD2-4A4F-973A-CE9C05FE2E21Q37638712-A922D168-C353-4091-9208-E543D86CC7C4Q37742631-2D73944F-C32C-42C9-B895-347A54C9452FQ43267025-F9A0239A-EDA9-4EA4-ADC4-07F8937DF0BFQ45394890-7CD5221E-2140-4542-BECE-0DC98111A1BCQ46974098-B0134191-0019-4E25-A99D-2816BC757089Q48334580-12A3DB90-D9FF-4B56-A2F1-F19F0A2DF1CEQ51401165-1B7924E5-72EF-42DC-9A7C-FDDFC2778C7DQ52926373-0EE60036-C905-4292-A8AE-116F7B4914DDQ52931658-49D60956-1B08-4991-96DD-1B93C0757F7D
P2860
Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Effects of drospirenone/17-bet ...... rtensive postmenopausal women.
@en
Effects of drospirenone/17-bet ...... rtensive postmenopausal women.
@nl
type
label
Effects of drospirenone/17-bet ...... rtensive postmenopausal women.
@en
Effects of drospirenone/17-bet ...... rtensive postmenopausal women.
@nl
prefLabel
Effects of drospirenone/17-bet ...... rtensive postmenopausal women.
@en
Effects of drospirenone/17-bet ...... rtensive postmenopausal women.
@nl
P2093
P1476
Effects of drospirenone/17-bet ...... rtensive postmenopausal women.
@en
P2093
George Bakris
Paul M Norris
Richard A Preston
Vladimir Hanes
William B White
P304
P356
10.1016/J.AMJHYPER.2004.12.003
P50
P577
2005-06-01T00:00:00Z